■ Home
■ About Us
■ Product
B.E.S.T. (BioEnergetics Science & Technology) Engineering, Corporation…home of the BioCharger.
Paul R. Begany, President & CEO 216-932-8158, 508-737-9935 begany@biocharger.net
Jim Girard, V.P. & Director Eng. 508-737-8468 girard@biocharger.net
Douglas Oringer, Director 808-988-5849 oringer@biocharger.net
THE NEW YORK HEALTH AND HEALING CENTER
Bio-Electric Light Stimulation Study
NYHH
New York
Health & Healing Center
118 West 72nd Street New York, NY 10023 212-595-4195
A PRELIMINARY STUDY OF THE EFFECTS OF BIO-ELECTRIC LIGHT STIMULATION
ABSTRACT:
The BELS (Bio-Electrical Light Stimulator) Unit is a high voltage, high frequency air core resonant transformer (Tesla Coil) which charges vacuum tubes filled with noble and common gases (Hydrogen, Helium, Neon, Argon, Krypton, Xenon, Nitrogen, Oxygen, Air and Water Vapor). It simultaneously transmits a broadband of frequencies from about 500,000 hertz into the gigahertz or visible light range, which discharge through the vacuum tubes to excite the gases and provide a form of color therapy.
The process of developing the BELS (Bio-Electric Light Stimulation) modality was undertaken by Healing Machines Incorporated of La Conner, Washington. Recognizing that the language of the body is mostly electrical and not biochemical, HMI reconstructed work performed in the early 1920's by Professor Georges Lakhovsky. Prof. Lakhovsky studied the functional aspects of different biological entities. He showed that different functional states, including pathological ones in which the body finds itself are characterized by specific electromagnetic interactions of the organism with the surrounding medium. In his book ""The Secret of Life", Lakhovsky explained that static magnetic fields penetrate the body with relative ease. These fields deform atomic and molecular structures that exert forces on microscopic components of the body. This physical effect in turn causes modification of various biochemical processes, thereby affecting cellular control mechanisms. The intensity of the biological consequences of electromagnetic fields can be different, ranging from disruption of the organism to complete healing.
Background:
Planning for the BELS study began in early 1996. Similar devices were being used by several practitioners in the United States for Chronic Fatigue Syndrome, as well as Arthritis and other pain syndromes. The success in dealing with these syndromes was encouraging and it was decided that preliminary studies be conducted in a more formal setting. It was also pointed out by the Researchers that HIV+ patients were exhibiting modified and similar profiles of CFS. Both conditions were characterized by ineffective and overwhelmed immune systems.
In designing the study, it was decided that patients be selected from as wide a range of the disease spectrum as possible. Patients were chosen from a group of people with varying degrees of illnesses which included Aids, Chronic Fatigue Syndrome, and Pain disorders.
Methods:
To test the BELS unit and using the Lakhovsky hypothesis, ten patients were selected. They ranged from thirty to seventy-two years of age. The treatment period was over ten weeks, during which time, patients were treated two to three times per week depending on the severity of the condition and the response each individual had toward therapy. Initially, the patients received test exposures to the units, ranging from two to five minutes and gradually progressed to sessions of fifteen to twenty minutes. Various distances were tried ranging from one to three feet from the unit and eventually a standard distance of two feet was used. NONE of the patients were taking any allopathic medications at the time of the study. Patients were also encouraged to continue with whatever natural remedies they were using.
For this PILOT study, the outline for recommended testing was quite broad. With an alternative modality such as BELS, it was impossible to know which laboratory tests would best represent and demonstrate accurate results. It seemed logical to cover as many bases as possible. The following tests were performed:
BLOOD CHEMISTRIES:
GLUCOSE SGOT
UREA NITROGEN SGPT
CREATININE LDH
SODIUM ALKALINE PHOSPHATE
POTASSIUM GAMMA GTP
CHLORIDE URIC ACID
CARBON DIOXIDE CALCIUM
PROTEIN PHOSPHORUS
ALBUMIN CHOLESTEROL
GLOBULIN TRIGLYCERIDES
A/ G RATIO IRON
BILIRUBIN - TOTAL & DIRECT
HEMATOLOGY:
WBC MCHC
RBC NEUTROPHILS
HEMOGLOBIN LYMPHOCYTES
HEMATOCRIT MONOCYTES
McV EOSINOPHILS,
MCH
ELECTROCARDIOGRAMS
Remarkably all of the above tests showed nearly identical results when repeated at the conclusion of the treatment period. We did rely heavily on the state of the art polymerase Chain Reaction (PCR) technology for all our HIV positive patients. (See next section for results)
The gathering of clinical data from Doctor, nurse or technician was extremely important. Each patient visit was extensively documented and questionnaires were completed before and aftereach treatment. The patient was also asked to fill out a questionnaire after each visit so that subjective and objective recordings were made.
As an alternative treatment study, every attempt was made to insure that patients were not receiving any chemical or allopathic treatments during the testing period. We had no desire to divert patients from AZT, DDI, anti-inflammatories or any other drugs. Obviously, we did not do a double-blind placebo study. Without compromising the efficacy of the BELS, our staff collected scientifically valuable data while focusing on improving daily quality of life of the patients involved.
Before continuing, several caveats need to be addressed when a small study is published. This study, as stated earlier, was neither randomized nor blinded with respect to treatment - conditions that should always make one wary of possible bias and consequences of the placebo effect. The author acknowledges this fact, but feels that the consistency of the positive effects were such that the clinical results could not be due to chance alone. Nevertheless, a prospective, randomized trial of BELS in a similar, larger population of patients should be considered before an approach to this type of therapy is adopted.
Another specific caveat is that the investigators chose to examine only short term (ten week) outcomes. There is question to whether treatment lasting longer than ten weeks would produce persistently beneficial effects.
The BELS modality crosses many theoretical boundaries and as such is not limited to any of them. Because BELS does not correspond to anything in the established medical repertoire, it has no natural constituency and must rely on satisfied patients and doctors for its support. Further studies by independent physicians should be done to correlate the effects of treatment so that the results are consistent and reproducible.
The primary goal of any PILOT study is to determine whether there is reason to advance to further studies while making absolutely certain that individuals NOT be harmed in any way and that these same individuals benefit from their participation in the study. We believe that the results of this study clearly indicate and warrant advancing to BELS 11.
Discussion:
Traditional medicine conceptualizes the body as a grand biochemical computer controlled by the brain and peripheral nervous system. A new paradigm sees human beings as vast networks of complex electromagnetic fields that interface with physical and cellular systems. Healing uses specialized forms of energy to positively affect those energetic systems that may be out of balance due to disease states. By rebalancing the energy fields in order to regulate cellular physiology, various electronic devices attempt to restore order to a higher level of function.
The human body, from an energetic standpoint, when weakened or shifted from its normal equilibrium, oscillates at a different and less harmonious frequency than when healthy. This abnormal frequency reflects a general state of cellular imbalance in the physical body. When a weakened individual is unable to shift his energy to the needed frequency to allow the immune system to properly define itself, a number of chemical and electrical abnormalities follow. At this stage, a certain amount of subtle electromagnetic help may be necessary. If this same individual is supplied with a dose of the needed energetic frequency, it allows the cellular bioenergetic systems to resonate in the proper vibrational mode, thereby combating the toxicity of the illness. This frequency specific subtle energy bond can allow the body and associated biochemical systems to return to a new level of hemostasis. By providing this needed subtle energy change, the BELS unit can provide the body significant non-toxic therapeutic benefits. Although the results from a small uncontrolled study of the beneficial effects are exciting, optimism must continue to be cautious. The exact mechanisms of benefit and the long term effects of this therapy remain to be established. We look forward to the prospective validation of this promising preliminary study.
Final Physical Examinations of BELS Study Patients
The New York Health & Healing Center
118 West 72ndStreet
New York, NY 10023
From: Joseph Carozza, M.D. Date: December 24, 1996
Re: Clinical Summary of 10 patients participating in BELS study from September 1996 to December 1996.
From September of 1996 to December of 1996, 1 examined ten patients who were involved in the Bio-Electrical Light Stimulation (BELS) program. The BELS Study involved exposing patients to electro-magnetic fields for five to twenty minutes three times per week. I completed histories and physicals on these patients and the following are my clinical findings:
Duration: The BELS study ran for a period of ten weeks. Patients were treated on a two to three times per week basis. At the conclusion of the formal treatment portion of the Study, a number of patients opted for participation on a one time per week Maintenance program.
Population: A total of ten patients began the Study. Of these, six were HIV-positive.
Of the ten patients:
• Seven received the full ten weeks of treatment
• One stopped treatment early because she felt that her problems were resolved and had no desire to continue treatment
• One patient was requested to leave
• One entered the Study late and completed eight weeks of treatment
Of the ten patients examined/ seven were males and three were females. The average age was 44.6 years.
The Patient Population divided into two segments:
A. Active: Those who completed the study and have remained on the Maintenance program;
B. Drop-Outs: Those who left before the end of the Study and never completed treatment.
Group A: (Active)
Our clinical examinations disclosed the following conclusions in addition to changes in clinical conditions as contracted with the information disclosed by the intake evaluations performed by the facilitator who saw the patients on a weekly basis during the Study:
Oral Cavity: Two of the patients had Thrush. Upon final examination, one cleared up completely and the other was markedly improved.
Lymphadenopathy: On physical examination, one of the patients had lymphadenopathy which resolved by the end of the Study.
Skin: Three of the patients at the beginning of the Study were diagnosed with Kaposi's Sarcoma. Of the three KS patients, one improved dramatically, one improved moderately and one remained unchanged.
Mood Changes: Many instances of depression and other emotional problems were reported in the Intake. With the exception of a single patient who opted to return to anti-depressants she had been formerly taking, all of the patients exhibited generally cheerful, optimistic outlooks.
Fatigue: Initially, there were subjective complaints of fatigue by most of the patients. At the conclusion of the Study, all ten are leading normal lives and stated that they had increased levels of energy.
Clinical Procedures: Vital signs were recorded by the study clinician at each visit. Approximately one hour was spent per patient per treatment.
Pulse: Initially, many pulse rates were rapid and approximately 90. At final exam, all patients exhibited strong, regular pulse rates of 60 to 80.
Temperature: Temperatures which were largely normal as reported at the time of Intake, remained normal at the time of final examination.
Weight Loss: All patients maintained their normal weight through the span of the Study.
Night Sweats: Many patients complained of recurrent episodes of this malady upon entering the Study. None reported any incidents of the problem at the time of final examination.
General Physical Stamina: According to preliminary reports, several patients complained of limited physical strength and fatigue. At the final examination, all reported that they are now leading normal and demanding physical lifestyles. Many have resumed regular workout sessions.
Medical Overview: Of the ten patients studied, nine patients stated that they felt better. One patient who complained of severe jaw and oral cavity pain left the study early because she was completely pain free after a few weeks. Another patient who complained of severe Chronic Fatigue stated that he was able to resume his post graduate studies and strenuous lifestyle after treatments. One patient stated that she felt worse. Our oldest patient - age 72 - insisted on bringing her old laboratory studies which were several months old and refused to do baseline studies with the exception of her electrocardiogram. Her initial complaint was Chronic Fatigue Syndrome. After several weeks on the treatment protocol she was extremely energetic. Because this was a completely foreign feeling for her she was extremely agitated. She returned to medication previously prescribed by her physician and it was mutually agreed that she should discontinue the Study and she was asked to leave. All of the above patients as well as the six mentioned in the following discussion were off all Allopathic Medicines and were urged to pursue only natural remedies if they were to do anything outside of the study. All laboratory and physical baseline tests including physical examination, hematology, urinalysis, blood chemistries and electrocardiographs remained normal, unchanged or improved with the exception of the PCR tests. (See Chart # 1)
The following six patients were HIV-positive and the following observations were noted. In general, almost all of the symptoms associated with HIV+ were treated successfully with the BELS unit. These included, ringing in the ears, poor memory, chest pains, oral thrush, blurred vision, severe fatigue, intermittent headaches, shortness of breath, night sweats, insomnia, diarrhea, flushing and sweating. All cardiograms remained unchanged. Laboratory work which included system analysis, such as liver enzymes and kidney function as well as complete blood work were unremarkable. CD4 (T4) lymphocyte levels were not followed since in our opinion, they are not a strong indicator of improvement or decline. Instead, we chose to use the PCR or Polymerase Chain Reaction to study the patient's actual viral loads. (See appendix)
